The Department of Justice and Federal Trade Commission request that Bayer Corp. conduct randomized placebo-controlled trials to support structure/function claims for Phillips’ Colon Health probiotic supplement would impose the same standard FDA requires for drug claims.
FTC Requests Drug Claim Support For Bayer Probiotic Supplement
On behalf of the FTC, DoJ alleges Bayer violated a 2007 settlement to substantiate supplement claims and asks a court to require the firm to provide two RCTs for dietary supplement claims for Phillips’ Colon Health. Trade groups rally behind the firm, arguing the requirement is unfair and illegal.